Navigation Links
Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
Date:9/12/2007
d compensation
expense - - - 405,699
Net loss for the year - - (23,018,090) (23,018,090)
-------------------------------------------------------------------------
Balance, June 30,
2006 - - (69,504,180) 35,304,518
-------------------------------------------------------------------------
Adjustment to opening
retained earnings for
change in accounting
policy related to
research inventory - - (3,225,599) (3,225,599)
Stock options exercised - - - 380,394
Stock options expired - - - -
Stock-based
compensation expense - - - 1,002,480
Issued pursuant to
private placement,
net - - - 23,964,751
Issued on acquisition
of NeuroMedix Inc.,
net - - - 9,858,143
Net loss for the year - - (16,961,790) (16,961,790)
-------------------------------------------------------------------------
Balance, June 30,
2007 - - (89,691,569) 50,322,897
-------------------------------------------------------------------------
-------------------------------------------------------------------------
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended June 30
(in Canadian dollars)
2007 2006
$ $
-------------------------------------------------------------------------
OPERATING ACTIVITIES
Net loss for the year (
'/>"/>
| SOURCE Transition Therapeutics Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Mans Transition from Foragers to Agriculturalist Led to Increase in Birth Rates
2. Rocky Transition to the Medicare Drug Program
3. Customized Post Operation Care Offers Patients a Smooth Transition to Patients into the Community
4. Mental Health - NHS Trust Commences Specialist Transition Service
5. Permanent Weight Loss Requires Transition to Healthy Eating
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. PM announces a new health care order for India
9. Ramdoss Announces Introduction of RCH-II
10. Britain Announces Third Transfusion Related Mad Cow Case
11. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
Post Your Comments:
(Date:5/24/2013)... May 24, 2013 ShopPharmacyCounter.com PhenObestin 37.5 ... ShopPharmacyCounter.com have announced price reductions on their popular PhenObestin ... which helps clients to lose weight as effortlessly as ... 37.5 by more than 50%. , Bottles have been ... time and all orders will receive free shipping. ...
(Date:5/24/2013)... Range Kleen Mfg. strives to “TCOTC.” Our ... from the President's desk to the Shipping Dock.” We hold ... and having passion while creating excellence and quality being results ... to do the right thing and what better way to ... by devastation. , Throughout the year Range Kleen donates to ...
(Date:5/24/2013)... Before you start the grill, before you watch ... Lee Gifford and Hoda Kotb on the Today Show on Memorial ... ideas to Kathie Lee and Hoda, including the new LawnBott® LB75 ... and women in the military who made the ultimate sacrifice for ... time with friends and family and enjoy the day. With ...
(Date:5/24/2013)... York (PRWEB) May 24, 2013 ... DePuy hip recall continue to move forward in courts ... to documents filed in California’s San Francisco Superior Court ... an expedited trial of her DePuy hip lawsuit is ... DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. Super. ...
(Date:5/24/2013)... for heart failure appear to have better odds of ... morning, a new study finds. Death rates and ... admitted in January, on Fridays and overnight, according to ... Saturday in Portugal at the annual meeting of the ... "The fact that patients admitted right before ...
Breaking Medicine News(10 mins):Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2[0] ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On[0] Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma[0] LawnBott® Visits the Today Show with Kathie Lee and Hoda[0] DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case[0] Monday Best Time for Hospitalization With Heart Failure, Study Says
... of SEIU UHW will hold a news conference at 3 p.m. ... to release newly obtained information showing that ousted union President Sal ... attorney that some of the actions may be illegal but took ... to cover them up. , , The documents detailing ...
... WAYNE, N.J., July 9 Today, Bayer HealthCare Pharmaceuticals ... designed to make infusion of recombinant factor VIII easier ... caregivers. The centerpiece of the program is an ... allows patients to practice the technique of self-injection without ...
... who had first period before age 12 are at increased risk ... Among women with ovarian cancer, those who had their first menstrual ... menstrual cycles over a lifetime are more likely to die of ... study shows. , U.S. researchers analyzed data on 410 women, aged ...
... cardiac CT for low-risk chest pain patients in the emergency ... may reduce a patients length of stay and hospital charges, ... School of Medicine, Seattle, WA. The SOC workup, which is ... tests, ECGs and nuclear stress testing. , , Fifty ...
... ... ... Drug Information Association (DIA), in collaboration with the Generic Pharmaceutical Association (GPhA), PhRMA, ... Registration--FDA and Industry: Overview and Lessons Learned on SPL (August 11-12; Philadelphia, PA) ...
... ... ... The American Academy of Orthopaedic Surgeons (AAOS) has opened the call for submissions to its ... musculoskeletal health issues and healthy behaviors in the care of bones, joints and muscles. ...
Cached Medicine News:Health News:Newly Obtained Information Shows That Ousted Union Leaders Plotted and Covered Up Wrongdoing 2Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 2Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 3Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 4Health News:Bayer HealthCare Launches Hemophilia Self-Infusion Training Program 5Health News:Early Menstruation Lowers Odds of Surviving Ovarian Cancer 2Health News:Early Menstruation Lowers Odds of Surviving Ovarian Cancer 3Health News:DIA Workshop Features Industry and FDA for Discussion of Best Practices for Electronic Establishment Registration and Product Listing 2Health News:Got Moving Stories? Calling All Reporters, Writers, Producers and Editors 2Health News:Got Moving Stories? Calling All Reporters, Writers, Producers and Editors 3Newly Obtained Information Shows That Ousted Union Leaders Plotted and Covered Up WrongdoingBayer HealthCare Launches Hemophilia Self-Infusion Training ProgramEarly Menstruation Lowers Odds of Surviving Ovarian Cancer Cardiac CT is more cost effective when managing low-risk patients with chest painDIA Workshop Features Industry and FDA for Discussion of Best Practices for Electronic Establishment Registration and Product ListingGot Moving Stories? Calling All Reporters, Writers, Producers and Editors
(Date:5/24/2013)... N.C. , May 24, 2013 Regulatory ... the forefront of many organizations, priority list. ... medical device sectors understand a strong Medical ... challenges in clinical development, market education , ... to create a vital bridge between an organization ...
(Date:5/24/2013)... N.J. , May 24, 2013 BD (Becton, Dickinson ... medical technology company, announced today that it will present at ... on Thursday, May 30, 2013, at 10:40 a.m. (ET). ... accessed from the BD corporate website at www.bd.com/investors ... 2013. About BD BD is ...
(Date:5/24/2013)... Calif. , May 24, 2013 /PRNewswire-iReach/ -- Phoenix ... leading non-profit substance abuse services organization, is hosting its ... Beverly Hills Hotel on June 6, 2013. More than ... raise funds for the adolescent residential treatment centers, family ... as honor individuals whose accomplishments have positive influences on ...
Breaking Medicine Technology:Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3... Meets Primary Endpoint in,Rheumatoid Arthritis Patients Who ... -, NUTLEY, N.J., July 10, 2007 /PRNewswire/ ... Actemra Radiate (RheumAtoiD,ArthritIs Study in Anti-TNF FailurEs) ... with moderate to severe rheumatoid,arthritis (RA) who ...
... Humira Estimated to Increase the,Maximal Steady ... 100%,-, SAN DIEGO, July 09, 2007 ... biopharmaceutical company developing and,commercializing recombinant human ... the Enhanze(TM) Technology clinical trial,demonstrating improved ...
Cached Medicine Technology:Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis 2Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis 3Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,Arthritis 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 2Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 3Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 4Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society 5Actemra (tocilizumab) Third Phase III Study Results Show,Significant Improvement in Symptoms of Patients with Rheumatoid,ArthritisHalozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society
Phaco chopper, a combination of a modified microfinger and a pointed "quick chop" tip. For use in the left hand....
The titanium sleeve is coated with hydroxyapatite (HA) which allows vascular ingrowth, firmly secures the peg in the sphere, and enhances biocompatibility. To hold prosthetic eye. For improved occula...
... Brown nucleus cracker with straight shaft ... viscoelastic, thereby, maintains anterior chamber depth ... Accomplished with a design that keeps ... blocking outflow of viscoelastic. Available with ...
Epilation forceps straight ends size 3.5"....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |